Robert Walker, MD
Robert Walker, MD

Robert Walker, MD

Senior Vice President,
Chief Medical Officer
(Interim Head of R&D)

Dr. Walker is senior vice president, chief medical officer and interim head of research and development with responsibility for discovery, non-clinical and clinical research, and development activities. A specialist in internal medicine and pulmonary and critical care medicine, Dr. Walker has more than 30 years of experience in drug and vaccine development within the private and public sectors. He joined Novavax in 2022, after leading the development of RSV and COVID-19 vaccines at Meissa Vaccines, Inc. He previously served as Chief Medical Officer at the Biomedical Advanced Research & Development Authority (BARDA) in the U.S. Department of Health and Human Services and provided clinical development expertise to medical countermeasure programs, including Operation Warp Speed for COVID-19 vaccines and therapeutics, and to federal emergency responses to Zika, Ebola and influenza epidemics. Dr. Walker earned his Doctor of Medicine degree from the University of Maryland. He completed his internal medicine training at The George Washington University and completed his fellowship in pulmonary and critical care medicine at the University of Pennsylvania.